SCHEMBL22910192

SCHEMBL22910192

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4c(-c5ccc6ccccc6c5)ccc5c4-c4ccccc4C5(c4ccccc4)c4ccccc4)cc3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
CYP1A2 P05177 4/20 0.37
KDM4E B2RXH2 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
TP53 P04637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ADORA2A P29274 4/20 0.37
ADORA1 P30542 4/20 0.37
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
GSTP1 P09211 1/20 0.34
DHFR P00374 1/20 0.34
MAPT P10636 3/20 0.33
LMNA P02545 1/20 0.33
OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22910308 0.90 MEN1 (0.38) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2
SCHEMBL22910219 0.90 MEN1 (0.38) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2
SCHEMBL22910226 0.88 CYP11B1 (0.38) MEN1KMT2ACYP1A2ALDH1A1HSD17B10
SCHEMBL18463431 0.88 MEN1 (0.39) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2
SCHEMBL22059123 0.88 HDAC4 (0.37) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2
SCHEMBL18386122 0.86 MEN1 (0.36) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2
SCHEMBL19543729 0.86 MEN1 (0.36) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2
SCHEMBL17151577 0.86 MEN1 (0.37) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2
SCHEMBL22868892 0.86 MEN1 (0.36) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2
SCHEMBL22868581 0.86 MEN1 (0.37) MEN1KMT2ACYP1A2KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569453-B2 Polycyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2023-01-31 US disclosed
US-20210020848-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210020848-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME PPOX, NFE2L2, OGFOD1 MEN1 1055/4885KMT2A 425/4885CYP1A2 91/4885
US-11569453-B2 Polycyclic compound and organic light emitting element comprising same PPOX, NFE2L2, OGFOD1 MEN1 1055/4885KMT2A 425/4885CYP1A2 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.